RYOIX (Rydex:Biotech;Inv)
Net Asset Value: 48.45
1-Day Return:
-0.15 (-0.31%)
YTD Return as of 4/5/13:
17.03%
Classification: Health/Biotech Objective: Health/Biotech Open to New Investors: Yes
Lipper Rating
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
| Growth of $10,000
Total Returns (As of 4/05/2013)
More| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 17.03 | 30.80 | 20.34 | 16.94 | 13.09 |
| Classification | 14.95 | 22.65 | 15.66 | 12.19 | 11.14 |
| Index (S&P 500) | NA | NA | NA | NA | NA |
| % Rank in Class (1-best,100=worst) | 17 | 10 | 16 | 10 | 23 |
Fund Stats
More| Investment Objective: | Health/Biotech |
|---|---|
| Net Assets ($Mil) | 169.90 |
| Inception Date: | 4/1/98 |
| Manager Name, Tenure | Byrum/Dellapa/Harder, 1998 / 2005 / 2008 |
| Expense Ratio: | 1.36% |
|
Sales Charge:
Load Type:
|
No Load 0.00% 0.00% |
Top 10 Holdings (As of 10/31/12)
More| Company Name | Symbol | % Net Assets |
|---|---|---|
| Amgen Inc Ord | AMGN | 9.98 |
| Gilead Sciences Inc Ord | GILD | 8.45 |
| Celgene Corp Ord | CELG | 6.49 |
| Biogen Idec Inc Ord | BIIB | 6.43 |
| Alexion Pharmaceuticals Inc Ord | ALXN | 4.40 |
| Regeneron Pharmaceuticals Inc Ord | REGN | 4.34 |
| Vertex Pharmaceuticals Inc Ord | VRTX | 3.50 |
| Life Technologies Corp Ord | LIFE | 3.45 |
| Illumina Inc Ord | ILMN | 2.85 |
| Onyx Pharmaceuticals Inc Ord | ONXX | 2.57 |
| % of Total Holdings | 52.46 | |
